BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9791355)

  • 1. The use of cultured dermis in the treatment of diabetic foot ulcers.
    Grey JE; Lowe G; Bale S; Harding KG
    J Wound Care; 1998 Jul; 7(7):324-5. PubMed ID: 9791355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.
    Gentzkow GD; Iwasaki SD; Hershon KS; Mengel M; Prendergast JJ; Ricotta JJ; Steed DP; Lipkin S
    Diabetes Care; 1996 Apr; 19(4):350-4. PubMed ID: 8729158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
    Browne AC; Vearncombe M; Sibbald RG
    Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.
    Marston WA; Hanft J; Norwood P; Pollak R;
    Diabetes Care; 2003 Jun; 26(6):1701-5. PubMed ID: 12766097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis.
    Hanft JR; Surprenant MS
    J Foot Ankle Surg; 2002; 41(5):291-9. PubMed ID: 12400712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers.
    Naughton G; Mansbridge J; Gentzkow G
    Artif Organs; 1997 Nov; 21(11):1203-10. PubMed ID: 9384327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultured allogeneic skin cells are effective in the treatment of chronic diabetic leg and foot ulcers.
    Harvima IT; Virnes S; Kauppinen L; Huttunen M; Kivinen P; Niskanen L; Horsmanheimo M
    Acta Derm Venereol; 1999 May; 79(3):217-20. PubMed ID: 10384921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context.
    Allenet B; Parée F; Lebrun T; Carr L; Posnett J; Martini J; Yvon C
    Diabetes Metab; 2000 Apr; 26(2):125-32. PubMed ID: 10804327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: Interim results of a comparative efficacy randomized controlled trial.
    Tchanque-Fossuo CN; Dahle SE; Lev-Tov H; West KIM; Li CS; Rocke DM; Isseroff RR
    J Tissue Eng Regen Med; 2019 Aug; 13(8):1430-1437. PubMed ID: 31070860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
    Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
    Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood flow changes in diabetic foot ulcers treated with dermal replacement therapy.
    Newton DJ; Khan F; Belch JJ; Mitchell MR; Leese GP
    J Foot Ankle Surg; 2002; 41(4):233-7. PubMed ID: 12194513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers.
    Moustafa M; Simpson C; Glover M; Dawson RA; Tesfaye S; Creagh FM; Haddow D; Short R; Heller S; MacNeil S
    Diabet Med; 2004 Jul; 21(7):786-9. PubMed ID: 15209775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
    Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
    Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study.
    You HJ; Han SK; Lee JW; Chang H
    Wound Repair Regen; 2012; 20(4):491-9. PubMed ID: 22672334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study.
    Han SK; Choi KJ; Kim WK
    Plast Reconstr Surg; 2004 Dec; 114(7):1783-9. PubMed ID: 15577349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Dermagraft': a new treatment for diabetic foot ulcers.
    Edmonds ME; Foster AV; McColgan M
    Diabet Med; 1997 Dec; 14(12):1010-1. PubMed ID: 9455927
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue therapy with autologous dermal and epidermal culture cells for diabetic foot ulcers.
    Marcelo D; Beatriz PM; Jussara R; Fabiana B
    Cell Tissue Bank; 2012 Jun; 13(2):241-9. PubMed ID: 21442296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total contact cast for neuropathic diabetic foot ulcers.
    Ali R; Qureshi A; Yaqoob MY; Shakil M
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):695-8. PubMed ID: 18983793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.